# AN2 Therapeutics, Inc. (ANTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ANTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -18.21M | $ -19.07M | $ 0 | $ 75.92M |
| 2025 | $ 0 | $ -36.02M | $ -30.55M | $ 0 | $ 53.06M |
| 2024 | $ 0 | $ -53.94M | $ -51.77M | $ 0 | $ 81.85M |
| 2023 | $ 0 | $ -69.99M | $ -57.62M | $ 0 | $ 124.70M |
| 2022 | $ 0 | $ -45.75M | $ -37.38M | $ 53.0K | $ 95.37M |
| 2021 | $ 0 | $ -25.61M | $ -24.35M | $ 0 | $ 61.91M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 14.32 |

## Other views

- [Metrics](https://sponda.capital/en/ANTX.md)
- [Charts](https://sponda.capital/en/ANTX/charts.md)
- [Compare](https://sponda.capital/en/ANTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.